A recent study indicates that people who come off popular GLP-1 drugs like Mounjaro or Wegovy may regain lost weight far faster than those who stop traditional lifestyle programs.
Research printed in a major health publication points out that while overweight people often shed a large proportion of their total mass while using the jabs, the weight returns at an average rate of nearly a kilo each month upon discontinuation.
"Individuals purchasing these drugs should be aware of the potential of quick rebound weight gain when the therapy ends," warns lead investigator Dr. Susan Jebb.
This pace of regain means a return to original weight within about 18 months.
Weighing Approaches
The research, which looked at dozens of trials involving over 9,000 of patients, compared the outcomes of the injectable medications with conventional dieting.
Scientists emphasize that individuals who shed pounds through dieting usually see a more gradual weight regain—approximately 0.1 kg a month—once they finish.
Understanding the Rapid Rebound
Experts suggest the mode of action of the injections explains the accelerated rebound.
GLP-1 drugs imitate a natural hormone called glucagon-like peptide-1, which controls hunger.
"Long-term administration of the hormone levels several times higher than normal could lead to the system to generate a reduced amount of its endogenous GLP-1, and may also diminish sensitivity to its effects," said Dr. Adam Collins, a nutrition researcher.
"Stopping of this hormone supplement results in appetite is uncontrolled, making excessive eating a significant risk."
An Ongoing Condition?
Health authorities recommend the jabs for people with weight-linked health risks, alongside recommended lifestyle changes.
A number of clinicians say that, due to the high risk of weight regain, the treatment might need to be ongoing.
This perspective is reinforced by pharmaceutical companies, who note that the results "emphasize the persistent nature of obesity," akin to managing conditions like high blood pressure.
Patient Experiences
Users who have discontinued the medication describe a powerful return of cravings.
"I experienced a switch flipping and you become extremely hungry," said an individual.
The struggle is exacerbated if patients have not established sustainable lifestyle or habit modifications during treatment.
Widespread Adoption
Recent estimates indicate that millions of adults in the UK have tried weight-loss jabs in the last 12 months, with interest remaining high.
- Use is higher among women than men.
- The middle-aged age group shows the greatest usage rates.
- A large proportion obtain the drugs through private prescriptions rather than public health services.
In conclusion, researchers stress that while the jabs are potent agents for shedding pounds, they are not a magic fix and maintained weight loss likely depends on ongoing lifestyle changes.